Once the PD-1/PD-L1 axis is sufficiently inhibited through a blocking antibody, rapid RT-associated nTeff influx is no longer suppressed (as observed under RT monotherapy), and active dTeff may build up in tumor tissue and exert their inhibitory effects on tumor growth (Fig. 3a). Here, CD274 is linked to neoplasm.